PortfoliosLab logo
Kineta Inc. (KA)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

IPO Date

Feb 11, 2016

Highlights

Market Cap

$7.05M

EPS (TTM)

-$1.64

EBITDA (TTM)

-$2.59M

Year Range

$0.39 - $0.89

Target Price

$13.50

Short %

0.31%

Short Ratio

0.68

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Kineta Inc.

Performance

Performance Chart


Loading data...

S&P 500

Returns By Period


KA

YTD

N/A

1M

N/A

6M

N/A

1Y

N/A

3Y*

N/A

5Y*

N/A

10Y*

N/A

^GSPC (Benchmark)

YTD

0.51%

1M

6.15%

6M

-2.00%

1Y

12.92%

3Y*

12.68%

5Y*

14.19%

10Y*

10.85%

*Annualized

Monthly Returns

The table below presents the monthly returns of KA, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-28.93%-68.22%-35.98%7.43%-17.55%14.19%12.99%6.67%7.81%-2.75%-28.45%-86.77%
202317.80%-11.50%-50.00%19.94%-24.18%-14.29%-18.22%-5.69%70.85%24.71%-8.84%-6.08%-42.83%
2022-34.12%-41.54%31.58%-26.67%-3.64%71.70%-10.99%5.56%-8.19%6.37%7.19%-49.32%-69.35%
20215.29%-0.73%1.86%-7.51%-8.12%-24.25%-22.06%18.94%-4.44%-11.34%-53.99%-29.69%-82.59%
2020-26.75%-6.59%-26.92%43.86%-20.12%4.58%7.30%-8.16%-18.52%-11.18%8.50%-19.81%-62.72%
2019-6.79%36.42%-69.42%-12.70%-10.73%-0.61%-15.68%-7.78%11.33%-1.78%193.98%-6.56%-29.63%
2018-20.58%-35.42%58.86%6.53%-4.35%-42.36%-11.11%8.47%-10.41%157.68%-18.36%-36.09%-44.43%
201720.31%-1.36%-46.25%-22.70%-34.49%18.18%-39.32%-23.59%-3.23%-10.48%37.77%125.10%-52.45%
2016-9.64%60.67%-6.22%82.74%-26.57%-8.49%28.92%8.94%-54.33%47.89%16.43%84.64%
Go deeper with the Portfolio Analysis tool — backtest performance, assess risk, compare to benchmarks, and more

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of KA is 15, meaning it’s performing worse than 85% of other stocks on our website when it comes to balancing risk and reward. Below is a breakdown of how it compares using common performance measures.


The Risk-Adjusted Performance Rank of KA is 1515
Overall Rank
The Sharpe Ratio Rank of KA is 1717
Sharpe Ratio Rank
The Sortino Ratio Rank of KA is 1717
Sortino Ratio Rank
The Omega Ratio Rank of KA is 1616
Omega Ratio Rank
The Calmar Ratio Rank of KA is 44
Calmar Ratio Rank
The Martin Ratio Rank of KA is 2020
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Kineta Inc. (KA) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


There isn't enough data available to calculate the Sharpe ratio for Kineta Inc.. This metric is based on the past 12 months of trading data. Please check back later for updated information.


Loading data...

Go to the full Sharpe Ratio tool to analyze any stock or portfolio. Customize time frames, set your own risk-free rate, and more

Dividends

Dividend History

Kineta Inc. provided a 0.00% dividend yield over the last twelve months, with an annual payout of $0.00 per share.


0.00%50.00%100.00%150.00%$0.00$2.00$4.00$6.00$8.00$10.0020222023
Dividends
Dividend Yield
PeriodTTM20232022
Dividend$0.00$0.00$10.01

Dividend yield

0.00%0.00%157.64%

Monthly Dividends

The table displays the monthly dividend distributions for Kineta Inc.. The dividends shown in the table have been adjusted to account for any splits that may have occurred.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2023$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
2022$10.01$10.01

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


Loading data...

Worst Drawdowns

The table below displays the maximum drawdowns of the Kineta Inc.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Kineta Inc. was 99.99%, occurring on Apr 15, 2024. The portfolio has not yet recovered.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.99%Jun 13, 20161973Apr 15, 2024
-25.79%Mar 10, 201612Mar 28, 201628May 5, 201640
-16.42%Feb 12, 201614Mar 3, 20162Mar 7, 201616
-14.14%May 17, 20164May 20, 20163May 25, 20167
-3.38%Jun 8, 20161Jun 8, 20162Jun 10, 20163
Go to the full Drawdowns tool for more analysis options, including inflation-adjusted drawdowns, and more

Volatility

Volatility Chart

The chart below shows the rolling one-month volatility.


Loading data...

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Kineta Inc. over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.


Annual
Quarterly

0.0

Earnings Per Share

The chart presents the Earnings Per Share (EPS) performance of Kineta Inc., comparing actual results with analytics estimates. In the past quarter, the company did not meet analyst expectations for EPS, resulting in a surprise of -326.0%.


-40.00-30.00-20.00-10.000.0010.0020.0030.0020212022202320242025
-0.20
-0.21
Actual
Estimate

Valuation

The Valuation section provides an overview of how Kineta Inc. is priced in the market compared to other companies in the Biotechnology industry. It includes key financial ratios that help investors assess whether the stock is undervalued or overvalued.


PS Ratio

This chart shows the Price-to-Sales (P/S) ratio for KA relative to other companies in the Biotechnology industry. Currently, KA has a P/S ratio of 1.4. This P/S ratio is low compared to the industry average. It may indicate that the stock is undervalued relative to its revenue, or that the market expects slower growth or lower margins.

PB Ratio

The chart illustrates the Price-to-Book (P/B) ratio for KA in comparison with other companies in the Biotechnology industry. Currently, KA has a P/B value of 9.7. This P/B ratio is higher than most companies in the industry. It may suggest the stock is overvalued or that investors expect the company to generate high returns on its assets.

Income Statement



TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items